Articles citing this paper
Deprescribing in a family health team: a study of chronic proton pump inhibitor use
Kate Walsh 1 4 , Debbie Kwan 2 , Patricia Marr 2 , Christine Papoushek 2 , W. Kirk Lyon 3
+ Author Affiliations
- Author Affiliations
1 Pharmacist, Toronto Central Community Care Access Centre
2 Pharmacist, Toronto Western Family Health Team
3 Family Physician, Toronto Western Family Health Team
4 Correspondence to: Kate Walsh, 250 Dundas St West, Toronto, ON M5T 2Z6, Canada. Email: katewalsh478@gmail.com
Journal of Primary Health Care 8(2) 164-171 https://doi.org/10.1071/HC15946
Published: 30 June 2016
30 articles found in Crossref database.
Role of nurses in supporting proactive deprescribing
Wright David John,
Scott Sion,
Buck Jackie, Bhattacharya Debi
Nursing Standard. 2019 34(3). p.44
Association of patterns of multimorbidity with length of stay
Aubert Carole E.,
Schnipper Jeffrey L.,
Fankhauser Niklaus,
Marques-Vidal Pedro,
Stirnemann Jérôme,
Auerbach Andrew D.,
Zimlichman Eyal,
Kripalani Sunil,
Vasilevskis Eduard E.,
Robinson Edmondo,
Metlay Joshua,
Fletcher Grant S.,
Limacher Andreas, Donzé Jacques
Medicine. 2020 99(34). p.e21650
Implementation of Proton Pump Inhibitor Deprescription Protocol in Geriatric Residents
Avraham Ovadyah, Biglow Michael
Annals of Pharmacotherapy. 2018 52(8). p.747
Deprescribing interventions in primary health care mapped to the Behaviour Change Wheel: A scoping review
Isenor Jennifer E.,
Bai Isaac,
Cormier Rachel,
Helwig Melissa,
Reeve Emily,
Whelan Anne Marie,
Burgess Sarah,
Martin-Misener Ruth, Kennie-Kaulbach Natalie
Research in Social and Administrative Pharmacy. 2021 17(7). p.1229
Deprescribing intervention activities mapped to guiding principles for use in general practice: a scoping review
Coe Amy,
Kaylor-Hughes Catherine,
Fletcher Susan,
Murray Elizabeth, Gunn Jane
BMJ Open. 2021 11(9). p.e052547
Barriers and facilitators of implementing proactive deprescribing within primary care: a systematic review
Okeowo Daniel A,
Zaidi Syed Tabish R,
Fylan Beth, Alldred David P
International Journal of Pharmacy Practice. 2023 31(2). p.126
From the Editor: He aha te mea nui o te ao?
Dovey Susan
Journal of Primary Health Care. 2016 8(2). p.89
Using a Triple Aim Approach to Implement “Less-is-More Together” and Smarter Medicine Strategies in an Interprofessional Outpatient Setting: Protocol for an Observational Study
Lehky Hagen Monique,
Julen René,
Buchs Pierre-Alain,
Kaufmann Anne-Laure,
Gaspoz Jean-Michel, Verloo Henk
JMIR Research Protocols. 2019 8(7). p.e13896
Encouraging appropriate use of proton pump inhibitors: existing initiatives and proposals for the future
Mari Amir,
Marabotto Elisa,
Ribolsi Mentore,
Zingone Fabiana,
Barberio Brigida,
Savarino Vincenzo, Savarino Edoardo Vincenzo
Expert Review of Clinical Pharmacology. 2023 16(10). p.913
Determinants of and interventions for Proton Pump Inhibitor prescription behavior: A systematic scoping review
van Gestel L. C.,
Adriaanse M. A.,
Kanis S. L,
Mensink-Bout S. M.,
Schoones J. W.,
Numans M. E.,
Kiefte-de Jong J. C., van den Brink G.
BMC Primary Care. 2024 25(1).
A concept analysis of deprescribing medications in older people
Page Amy,
Clifford Rhonda,
Potter Kathleen, Etherton‐Beer Christopher
Journal of Pharmacy Practice and Research. 2018 48(2). p.132
Quality Improvement in Gastroenterology: A Systematic Review of Practical Interventions for Clinicians
Reynolds Courtney,
Esrailian Eric, Hommes Daniel
Digestive Diseases and Sciences. 2018 63(10). p.2507
When does proton pump inhibitor treatment become long term? A scoping review
Haastrup Peter Fentz,
Jarbøl Dorte Ejg,
Thompson Wade,
Hansen Jane Møller,
Søndergaard Jens, Rasmussen Sanne
BMJ Open Gastroenterology. 2021 8(1). p.e000563
Use and prescription appropriateness of drugs for peptic ulcer and gastrooesophageal reflux disease in hospitalized older people
Franchi C,
Mannucci PM,
Nobili A, Ardoino I
European Journal of Clinical Pharmacology. 2020 76(3). p.459
Proton pump inhibitors for upper gastrointestinal bleeding
Kherad Omar,
Restellini Sophie,
Martel Myriam, Barkun Alan
Best Practice & Research Clinical Gastroenterology. 2019 42-43 p.101609
Evolution of proton pump inhibitor prescribing from 2017 to 2021 at 14 secondary and tertiary hospitals in China：a multicentre cross-sectional study
Zeng Min,
Li Yuan,
Chen Tao,
Zhang Shengmin, Luo Hongli
BMJ Open. 2023 13(7). p.e072793
Proton pump inhibitor deprescription: A rapid review
Imparato Renata Rodriguez, Toma Tereza Setsuko
Brazilian Journal of Pharmaceutical Sciences. 2022 58
Analysis of deprescription strategies of proton pump inhibitors in primary care: a narrative review
Del-Pino Miguel, Sanz Emilio J.
Primary Health Care Research & Development. 2023 24
Deprescribing practices in Canada: A scoping review
Desai Mansi, Park Tanya
Canadian Pharmacists Journal / Revue des Pharmaciens du Canada. 2022 155(5). p.249
Critical Psychiatry (2019)
Quality improvement: A strategy to accelerate pharmacist integration into team-based primary care practice
Raiche Taylor,
Visentin Jessica D.,
Fernandes Lisa,
Crown Natalie, McCarthy Lisa M.
Canadian Pharmacists Journal / Revue des Pharmaciens du Canada. 2020 153(5). p.274
We have had a gutful: The need for deprescribing proton pump inhibitors
Naunton M.,
Peterson G. M.,
Deeks L. S.,
Young H., Kosari S.
Journal of Clinical Pharmacy and Therapeutics. 2018 43(1). p.65
Polypharmacy at discharge in older hospitalised patients in Vietnam and its association with frailty
Nguyen Thanh Xuan,
Nguyen Tu N.,
Nguyen Anh Trung,
Nguyen Huong Thi Thu,
Nguyen Thu Thi Hoai,
Nguyen Tam Ngoc,
Pham Thang, Vu Huyen Thi Thanh
Australasian Journal on Ageing. 2020 39(3). p.230
Trends in acid suppressant drug prescriptions in primary care in the UK: a population-based cross-sectional study
Abrahami Devin,
McDonald Emily Gibson,
Schnitzer Mireille, Azoulay Laurent
BMJ Open. 2020 10(12). p.e041529
Multimorbidity, polypharmacy and primary prevention in community-dwelling adults in Quebec: a cross-sectional study
Nguyen Tu N,
Ngangue Patrice,
Haggerty Jeannie,
Bouhali Tarek, Fortin Martin
Family Practice. 2019 36(6). p.706
Appropriateness of proton pump inhibitor therapy in an ambulatory geriatrics clinic: A retrospective cross-sectional analysis
Dixon Ryan, Bolt Jennifer
Canadian Pharmacists Journal / Revue des Pharmaciens du Canada. 2023 156(6). p.331
Education as a low-value improvement intervention: often necessary but rarely sufficient
Soong Christine, Shojania Kaveh G
BMJ Quality & Safety. 2020 29(5). p.353
Patient Values and Preferences Surrounding Proton Pump Inhibitor Use: A Scoping Review
Thompson Wade,
Black Cody,
Welch Vivian,
Farrell Barbara,
Bjerre Lise M., Tugwell Peter
The Patient - Patient-Centered Outcomes Research. 2018 11(1). p.17
Influencers on deprescribing practice of primary healthcare providers in Nova Scotia: An examination using behavior change frameworks
Kennie-Kaulbach Natalie,
Cormier Rachel,
Kits Olga,
Reeve Emily,
Whelan Anne Marie,
Martin-Misener Ruth,
Burge Fred,
Burgess Sarah, Isenor Jennifer E.
Medicine Access @ Point of Care. 2020 4 p.239920262092250
Successful deprescribing of proton pump inhibitors with a patient-centered process: the DESPIBP Project
Calvo Lamuela L. J.,
García Cámara P.,
Llorente Barrio M.,
Sierra Gabarda O.,
Monzón Baez R.,
Arbonés Mainar J. M.,
Alcedo González J., Bernal Monterde V.
European Journal of Clinical Pharmacology. 2021 77(12). p.1927
